XML 57 R36.htm IDEA: XBRL DOCUMENT v3.22.4
Net Loss Per Share (Tables)
12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
Schedule of Weighted Impacts of Outstanding Anti-dilutive Securities Excluded from Calculation of Diluted Net Loss Per Share

Potential common shares that would have the effect of increasing diluted earnings per share are considered to be anti-dilutive and as such, these shares are not included in the calculation of diluted earnings per share. The Company reported a net loss for each of the years ended December 31, 2022, 2021 and 2020. Therefore, dilutive common shares are not assumed to have been issued since their effect is anti-dilutive for these periods.

Diluted weighted average shares excluded the following potential common shares related to stock options, RSUs, PRSUs and TSR awards, and shares to be purchased under the 2014 Employee Stock Purchase Plan (“ESPP”) for the periods presented as they were anti-dilutive (in thousands):

 

 

 

Years Ended December 31,

 

 

 

2022

 

 

2021

 

 

2020

 

Employee stock options

 

 

9,520

 

 

 

8,461

 

 

 

6,694

 

RSUs, PRSUs and TSR awards

 

 

2,137

 

 

 

1,538

 

 

 

564

 

ESPP

 

 

305

 

 

 

417

 

 

 

306

 

 

 

 

11,962

 

 

 

10,416

 

 

 

7,564